The current valuation score of Acumen Pharmaceuticals Inc is 6.76, ranking 296 out of 389 in the Biotechnology & Medical Research industry. Its current P/E ratio is -1.22, which is -61.72% below the recent high of -0.47 and -601.43% above the recent low of -8.54.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.